Dudediligence.

Tevogen Inc

TVGNNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$5.9MSep ’24−$9.4MDec ’24−$10.4MMar ’25−$5.5MJun ’25−$5.7MSep ’25−$4.7MDec ’25−$5.4MMar ’26−$5.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating incomenone on filenone on file−$8.8M−$53.6M−$26.1M
Net incomenone on file$4.4M−$60.5M−$13.7M−$26.3M
Operating cash flownone on file−$215,395−$8.2M−$12.0M−$12.3M
Free cash flownone on filenone on file−$8.3Mnone on file−$12.4M
Cash$344,581$129,186$1.1M$1.3M$0.00
Debtnone on file$0.00none on filenone on filenone on file
Shares outstandingnone on file2.4M120.0M3.6M4.0M